Enrollment change • Trial completion date • Trial termination • Combination therapy • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
|
ER positive • HR positive • HER-2 negative • PGR positive
|
abiraterone acetate • fulvestrant • prednisone • AUR102